Related Experiment Video
Updated: Aug 8, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
Azzam Hamad1, Gaukhar M Yusubalieva2,3, Vladimir P Baklaushev2,3
1Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
Abstract:
Glioblastoma is the most aggressive form of malignant brain tumor. Standard treatment protocols and traditional immunotherapy are poorly effective as they do not significantly increase the long-term survival of glioblastoma patients. Oncolytic viruses (OVs) may be an effective alternative approach. Combining OVs with some modern treatment options may also provide significant benefits for glioblastoma patients. Here we review virotherapy for glioblastomas and describe several OVs and their combination with other therapies. The personalized use of OVs and their combination with other treatment options would become a significant area of research aiming to develop the most effective treatment regimens for glioblastomas.
Insights
Oncolytic viruses (OVs) show promise for treating aggressive glioblastoma when standard therapies fail. Combining OVs with other treatments could significantly improve patient survival and represents a key research area.
Area of Science:
- Neuro-oncology
- Virology
- Immunotherapy
Background:
- Glioblastoma is an aggressive brain tumor with poor prognosis.
- Current treatments like standard protocols and immunotherapy offer limited long-term survival benefits.
Purpose of the Study:
- To review oncolytic virus (OV) therapy for glioblastomas.
- To explore the potential of combining OVs with other therapeutic modalities.
Main Methods:
- Review of existing literature on virotherapy for glioblastomas.
- Identification and description of various OVs.
- Analysis of OV combinations with other treatment options.
Main Results:
- Oncolytic viruses (OVs) present a potential alternative to conventional glioblastoma treatments.
- Combinations of OVs with other therapies may enhance treatment efficacy.
- Personalized approaches integrating OVs are emerging.
Conclusions:
- Virotherapy, particularly with oncolytic viruses, offers a promising avenue for glioblastoma treatment.
- Combination strategies and personalized medicine are crucial for advancing glioblastoma therapy.
- Further research into OV combinations is essential for developing effective treatment regimens.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers

